Pfizer Case Study: Protecting Blockbuster Drugs from Generic Competition
Enregistré dans:
Format: | Électronique eBook |
---|---|
Publié: |
Marketline
2005
|
Accès en ligne: | Available in Business Source Ultimate. Voir à l'OPAC |
Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|
Documents similaires
Bristol-Myers Squibb Case Study: Overcoming the threat from generic Antidiabetics
Publié: (2005)
Publié: (2005)
Aliskirin Case Study: Will Aliskiren Live Up to the Hype & Achieve Blockbuster Status?
Publié: (2008)
Publié: (2008)
Amgen Case Study: Protecting Epogen from Competition
Publié: (2005)
Publié: (2005)
Pfizer's Maraviroc Case Study: Maraviroc is Close to Approval, Despite Hurdles Along the Way
Publié: (2008)
Publié: (2008)
Prevnar: the First Vaccine Blockbuster
Publié: (2008)
Publié: (2008)
Black Book - Pfizer Incorporated (1973)
Black Book - Pfizer Incorporated (1987)
Black Book - Pfizer Incorporated (1984)
Black Book - Pfizer Incorporated (1990)
Transition at Teva - Blockbuster Drug Copaxone to Lose Patent Protection in 2014
Publié: (2014)
Publié: (2014)
Millennium Pharmaceuticals Case Study: Growth From an Embryonic to Integrated Biotech
Publié: (2005)
Publié: (2005)
Lyrica Case Study: Building a Successful Drug Launch Strategy
Publié: (2008)
Publié: (2008)
Osteoporosis Drug Reformulation Case Study: Refreshing a Brand Through Reformulation
Publié: (2007)
Publié: (2007)
GlaxoSmithKline Case Study: Switching Drugs to OTC Status Effectively
Publié: (2008)
Publié: (2008)
Lyrica, Botox, Aricept & Hycamtin Case Study: the Benefits of New Drug Application Extensions
Publié: (2007)
Publié: (2007)
Iressa & Tarceva Case Study: Accounting for Different Levels of Success Among Near Identical Drugs
Publié: (2005)
Publié: (2005)
GSK, Wyeth & Forest Laboratories Case Study: Prolonging a Drug's Lifecycle in the Antidepressant Market
Publié: (2007)
Publié: (2007)
Avandia Case Study: How Negative Publicity Can Damage a Drug's Market Position
Publié: (2008)
Publié: (2008)
Topamax, Femara, & Torcetrapib Case Study: Utilizing Usage Extension to Broaden a Drug's Patient Base
Publié: (2007)
Publié: (2007)
Johnson & Johnson Case Study: Remicade, a Biotech Blockbuster
Publié: (2011)
Publié: (2011)
Lipitor Case Study: Lifecycle Management Strategies
Publié: (2005)
Publié: (2005)
Improving Growth & Profits: Roche Pharmaceuticals Case Study
Publié: (2005)
Publié: (2005)
Innovation: Putting Ideas into Action Bausch & Lomb Case Study
Publié: (2006)
Publié: (2006)
Singulair & Taxotere Case Study: Combining Indication Expansion Strategies
Publié: (2007)
Publié: (2007)
Fosamax Case Study: Lifecycle Management Strategies in the Osteoporosis Market
Publié: (2008)
Publié: (2008)
CNS Market Case Study: Leading Brands in the CNS Market
Publié: (2008)
Publié: (2008)
Journal of Herbal Drugs
Menactra Case Study: Developing Meningococcal Vaccines for all Age Groups
Publié: (2007)
Publié: (2007)
Black Book - Viacom Blockbuster: From Spectacular to Really Good
Roche, Schering & GlaxoSmithKline Case Studies: Pharmaceutical Project Management
Publié: (2005)
Publié: (2005)
Biogen Idec Case Study: Securing Long-Term Growth in the MS Market
Publié: (2007)
Publié: (2007)
Ambien, Lunesta & Rozerem Case Study: Successful DTC Advertising in the Insomnia Market
Publié: (2007)
Publié: (2007)
Inhalers Case Study: the Increasing Importance of Inhaler Devices in the Asthma/COPD Market
Publié: (2008)
Publié: (2008)
Pitney Bowes, CancerCompass, Bipolar Adherence Program for Seroquel Case Study
Publié: (2008)
Publié: (2008)
Pfizer & AstraZeneca Case Studies: Enhancing Sales Team Tactics
Publié: (2005)
Publié: (2005)
GSK & Sanofi Pasteur Case Study: Developing New Formulations & Combinations of Core Vaccines
Publié: (2008)
Publié: (2008)
Documents similaires
-
Bristol-Myers Squibb Case Study: Overcoming the threat from generic Antidiabetics
Publié: (2005) -
Aliskirin Case Study: Will Aliskiren Live Up to the Hype & Achieve Blockbuster Status?
Publié: (2008) -
Amgen Case Study: Protecting Epogen from Competition
Publié: (2005) -
Pfizer's Maraviroc Case Study: Maraviroc is Close to Approval, Despite Hurdles Along the Way
Publié: (2008) -
Prevnar: the First Vaccine Blockbuster
Publié: (2008)